FDA.reportPublic FDA data

FLEXBUMIN 25 % in 50 ML Injection

RxCUI
1742401
RxNorm name
FLEXBUMIN 25 % in 50 ML Injection
Display name
FLEXBUMIN 25 % in 50 ML Injection
Full name
FLEXBUMIN 25 % in 50 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
101452Buminate, FlexbuminAlbumin (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
bdb4e167-27a2-4b50-b245-43df9cd535cbFLEXBUMIN 25 % in 50 ML Injection [PSN] · 50 ML albumin human, USP 250 MG/ML Injection [Flexbumin] [SBD] · Flexbumin 12.5 GM per 50 ML Injection [SY] · Flexbumin 25 % per 50 ML Injection [SY]417These highlights do not include all the information needed to use FLEXBUMIN ® 25% safely and effectively. See full prescribing information for FLEXBUMIN 25%. FLEXBUMIN ® 25% Albumin (Human), USP, 25% Solution, for intravenous use Initial U.S. Approval: 200520241218